Author: admin
Recently, a client of Daxin, Lanfan Medical Co., Ltd. (hereinafter referred to as "Lanfan Medical", stock code 002382) publicly applied for the issuance of convertible corporate bonds and was approved by the 18th Issuance Review Committee of the China Securities Regulatory Commission in 2020 The 45th work meeting of the Issuance Review Committee.
Empower existing industries
Founded in 2002, Lanfan Medical is a leading medical device enterprise with complete layout of low- and medium-value consumables. Lanfan Medical PVC gloves account for 22% of the global market share. Cardiac stents and interventional cardiac surgery related equipment products have operations in more than 90 countries around the world, ranking fourth in the world in the field of heart stents.
In August 2019, Lanfan Medical disclosed the board's plan, the company plans to publicly issue convertible corporate bonds, the total amount of funds raised will not exceed RMB 3.144 billion. A series of projects to expand and deepen the development of the main business, empower existing industries.
As an audit institution for Lanfan Medical's public issuance of convertible bonds, Daxin sent a team of capable personnel to provide high-standard professional services throughout the project.
Capital support against "COVID-19"
On March 2 2020, the first working day after the implementation of the new "Securities Law", Lanfan Medical's public issuance of corporate bonds for professional investors was approved by the Shenzhen Stock Exchange and became the first batch of Shenzhen Stock Exchanges after the implementation of the registration system One of the "registered" corporate bonds. Daxin also provided auditing services.
It is reported that this publicly issued corporate bond is a corporate bond related to epidemic prevention and control, in order to ensure the continuous stable production and increase of supply of the company's prevention and control products during the epidemic, and further support the epidemic prevention and control work.
In addition, after the outbreak of New Coronavirus, Lanfan Medical donated 2 million medical-grade gloves for the first time in Wuhan. After the outbreak of the global epidemic, Lanfan Medical donated 200,000 gloves each from Japan, South Korea and Italy, and quickly switched production capacity to support overseas epidemic needs, and actively responded to supporting more than 50 million medical nitrile gloves overseas, covering 10 Several countries and regions.
The public issuance of convertible bonds by Lanfan Medical will consolidate its global competitiveness and gradually achieve its strategic goal of growing into a large integrated medical device giant.
Industry and capital dance together, and capital drives industrial upgrading and development. Daxin will provide assistance services for the financing needs of more enterprises in development.